New hope for kids with arthritis: drug combo tested in major trial
NCT ID NCT07386587
First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study tests whether adding etanercept to standard methotrexate treatment works better than methotrexate alone for children with juvenile idiopathic arthritis. About 60 children aged 2-16 with newly diagnosed polyarticular JIA will be enrolled. The goal is to see if the combination helps more children achieve low disease activity over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Child Health Sciences Lahore, The Children's hospital Lahore
Lahore, Punjab Province, 54600, Pakistan
Conditions
Explore the condition pages connected to this study.